
https://www.sciencedirect.com/science/article/pii/S221323172300407X
"Our study also proved for the first time that 90 consecutive days of HBOT still significantly improved AD-like cognitive function and pathological changes, which can provide a basis for subsequent clinical studies to develop HBOT treatment protocols for AD.”
https://link.springer.com/content/pdf/10.1007/s11065-021-09500-9.pdf
“Authors prospectively analysed 158 vascular dementia patients who were randomized in two groups: HBO treatment (12 weeks of HBOT sessions administered at 2 ATA for 60 min) and control group…Authors concluded that HBO therapy can improve cognitive functions in patients with vascular dementia.”
.jpg/:/cr=t:21.59%25,l:0%25,w:100%25,h:56.82%25/rs=w:515,h:234,cg:true)
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.